Article
A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy
25 Feb 2023
Abstract excerpt
Abstract Response to antiseizure medications (ASMs) can be influenced by several gene polymorphisms, causing either lower efficacy or higher occurrence of adverse drug reactions (ADRs). We investigated the clinical utility of salivary pharmacogenomic testing on epilepsy patients. A commercialized pharmacogenomic salivary test was performed in a cohort of epileptic patients. Genetic variants on five genes (i.e.,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
